IMDX INSIGHT MO DIAG
$1.66
INSIGHT MO DIAG (IMDX) Earnings News
Earnings press releases, previews and reviews for INSIGHT MO DIAG (IMDX), newest first. Our most recent is review: Insight Molecular Diagnostics Narrows Its Loss, but an FDA Data Gap Pushes GraftAssureDx Into 2027 and Brings a New Capital Raise.
Monday
November 16, 2026
6:45 PM ET
Insight Molecular Diagnostics Narrows Its Loss, but an FDA Data Gap Pushes GraftAssureDx Into 2027 and Brings a New Capital Raise
Earnings Whispers · Review
Monday
November 16, 2026
4:56 PM ET
IMDx Reports Third Quarter 2026 Results and Provides Corporate Update
Thursday
November 5, 2026
7:00 AM ET
iMDx to Release Third Quarter Results on November 16, 2026
Monday
August 10, 2026
4:05 PM ET
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Tuesday
August 4, 2026
7:00 AM ET
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference